ERBB2 and triple-negative breast carcinoma: Indeed, recent functional findings have demonstrated miR-1296-5p involvement in the regulation of breast cancer cell progression by targeting the ERBB2/mTORC1 signaling pathway [57] and tumor suppressor roles in triple-negative breast cancer [58,59,60].